Sponsor
Second Xiangya Hospital of Central South University
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Second Xiangya Hospital of Central South University appears in 66 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)NCT06951646 · lead sponsor · 2026-03-10
RECRUITINGGenetic Risk Score of Type 1 Diabetes Mellitus for Progression to Insulin in Diabetic Patients Lack of Predictive Value: a Multicenter Nested Case-control StudyNCT07621445 · lead sponsor · 2025-10-27
RECRUITINGMobile Health and Wearable Devices for Diabetes Complication ManagementNCT07129148 · lead sponsor · 2025-10-01
RECRUITINGEfficacy of Glycemic Improvement Project (GLITTER Study) in Type 1 Diabetes-GLITTER Study 2NCT07097818 · lead sponsor · 2025-08-18
RECRUITINGEfficacy and Safety of Attapulgite in Patients With Obesity: An Exploratory Clinical TrialNCT07103382 · lead sponsor · 2025-06-26
RECRUITINGHybrid Closed-Loop for Perioperative Glycemic Control in T2DM With Parenteral NutritionNCT07121504 · lead sponsor · 2025-06-26
RECRUITINGGlycemic Improvement With Team, Technology, Education and Peer Resources in Type 1 Diabetes-GLITTER StudyNCT07097805 · lead sponsor · 2025-01-01
RECRUITINGPropranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung CancerNCT05979818 · lead sponsor · 2024-11-13
RECRUITINGThe Associations of Sleep Disturbance With Therapy Efficacy and Prognosis of Lung CancerNCT06975384 · lead sponsor · 2024-11-01
RECRUITINGEnvironmental Determinants of Type 1 Diabetes RiskNCT07835724 · lead sponsor · 2024-08-01
RECRUITINGSafety and Efficacy of Fecal Microbiota Transplantation on Cognitive Function in T1DMNCT06496412 · lead sponsor · 2024-04-20
RECRUITINGPrecision Medicine of Diabetes Program in ChinaNCT06320600 · lead sponsor · 2023-07-01
RECRUITINGThe Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCCNCT05778253 · lead sponsor · 2023-03-23
RECRUITINGMulticenter Study of Fulminant Type 1 Diabetes in ChinaNCT05593081 · lead sponsor · 2022-05-20
RECRUITINGClinical Characteristics of People With Long-term Type 1 DiabetesNCT05359796 · lead sponsor · 2022-05-01
RECRUITINGChina Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 DiabetesNCT05498974 · lead sponsor · 2022-01-01
RECRUITINGExploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)NCT05598528 · lead sponsor · 2021-09-28
RECRUITINGThe Associations of Psychological Stress With Therapy Efficacy and Prognosis of Lung Cancer (STRESS-LUNG)NCT05477979 · lead sponsor · 2020-06-01
RECRUITINGChinese Alliance for Type 1 Diabetes Multi-center Collaborative ResearchNCT04096794 · lead sponsor · 2016-09-01
RECRUITINGThe Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight GainNCT07795554 · lead sponsor · 2026-09-01
NOT_YET_RECRUITINGA Relation Between Craving Induction and Treatment Response in Deep Transcranial Magnetic Stimulation (dTMS) for Reducing Antipsychotic-induced Weight Gain in SchizophreniaNCT07805980 · lead sponsor · 2026-09-01
NOT_YET_RECRUITINGBrain Functional Connectivity Mechanism of Cognitive Flexibility Impairment and rTMS Intervention in Major Depressive DisorderNCT07161492 · lead sponsor · 2026-07-01
NOT_YET_RECRUITINGMechanisms of Sulforaphane Supplementation in Alleviating Negative Symptoms and Cognitive Impairment in SchizophreniaNCT07652866 · lead sponsor · 2026-06-02
NOT_YET_RECRUITINGEffects of Cofrogliptin on Beta-Cell Function in LADA PatientsNCT07460336 · lead sponsor · 2026-05-15
NOT_YET_RECRUITINGEvaluation of Chiglitazar Sodium With Lifestyle Intervention for Reversing PrediabetesNCT07558525 · lead sponsor · 2026-04-18
NOT_YET_RECRUITINGEfficacy and Safety of Sorafenib in New-Onset Type 1 Diabetes MellitusNCT06227221 · lead sponsor · 2026-02-01
NOT_YET_RECRUITINGDiabetic Cardiovascular Complications: Multi-Omics AnalysisNCT06824233 · lead sponsor · 2025-03-01
NOT_YET_RECRUITINGComparison of Catheter Plus Marshall Vein Ablation vs. Catheter Ablation Alone in Persistent AF With Heart FailureNCT06578793 · lead sponsor · 2024-08-01
UNKNOWNctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction ChemoimmunotherapyNCT05822284 · lead sponsor · 2023-04-01
NOT_YET_RECRUITINGMechanistic Study of SPARC-Mediated Regulation of Neutrophil Extracellular Trap Formation in the Brain Metastatic Microenvironment of Breast CancerNCT07185646 · lead sponsor · 2023-01-01
ACTIVE_NOT_RECRUITINGA Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLCNCT05360979 · lead sponsor · 2022-05-15
UNKNOWNEffects Of Berberine Plus Inulin On Diabetes Care in Patients With LADANCT04698330 · lead sponsor · 2022-05-01
NOT_YET_RECRUITINGStudy of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney DiseaseNCT07359027 · lead sponsor · 2021-11-02
COMPLETEDThe Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.NCT05005741 · lead sponsor · 2021-05-01
UNKNOWNAutomated Structured Education Based on an App and AI in Chinese Patients With Type 1 DiabetesNCT04016987 · lead sponsor · 2020-09-08
UNKNOWNA Study of Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)NCT04636762 · lead sponsor · 2020-06-01
COMPLETEDEffect of Needle-free Jet Injection of Insulin on Glucose Control and Injection Feelings in Type 1 Diabetic PatientsNCT04094740 · lead sponsor · 2019-10-01
UNKNOWNAltered Faecal Microbiome and Metabolome in CT1D, AT1D and T2DNCT05252728 · lead sponsor · 2019-02-01
COMPLETEDMulti-center Registration Study of Adult Onset Still's Disease in Chinese PopulationNCT03651193 · lead sponsor · 2018-11-28
UNKNOWNFish Oil as Adjunct Treatment for Major Depressive DisorderNCT03295708 · lead sponsor · 2017-10-01
UNKNOWNMetformin Plus Insulin on Non-obese Autoimmune DiabetesNCT03513874 · lead sponsor · 2017-08-01
UNKNOWNEfficacy and Safety of Jinshuibao Capsule on Diabetic Kidney DiseaseNCT03164785 · lead sponsor · 2017-07-24
COMPLETEDLiraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes MellitusNCT03011008 · lead sponsor · 2017-01-01
UNKNOWNSafety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune DiabetesNCT03011021 · lead sponsor · 2017-01-01
UNKNOWNStudy on Predictiors and Mechanism of Conversion to Psychosis in Individuals at Ultra-high Risk GroupNCT03965598 · lead sponsor · 2016-11-01
UNKNOWNSafety Study and Therapeutic Effects of Umbilical Cord Blood Treg on Autoimmune DiabetesNCT02932826 · lead sponsor · 2016-10-01
UNKNOWNCohort Study of Patients With Type 1 DiabetesNCT03610984 · lead sponsor · 2016-10-01
COMPLETEDProtective Effects of Saxagliptin (And Vitamin D3) on β Cell Function in Adult-onset Latent Autoimmune DiabetesNCT02407899 · lead sponsor · 2015-03-01
COMPLETEDOptical Coherence Tomography Quantitative Analysis of Changes in Anterior Chamber After Laser Peripheral LridotomyNCT02279472 · lead sponsor · 2014-10-01
UNKNOWNGenome-wide Association Study of Different Types of Diabetes and Construction of Genetic Risk ScoreNCT06791330 · lead sponsor · 2010-01-01
COMPLETEDLiquid Biopsy-Based Novel Modality for Postoperative Management of Lung CancerNCT06930807 · collaborator · 2025-03-25
RECRUITINGThe Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment SystemNCT07136025 · collaborator · 2025-02-01
RECRUITINGChronic Airway Disease and Multimorbidity CohortNCT06798077 · collaborator · 2025-02-01
RECRUITINGStudy of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)NCT06911606 · collaborator · 2024-05-22
RECRUITINGhiPSC-CMs-loaded Chitosan Patch to Treat Severe Chronic Ischemic Heart DiseaseNCT07471698 · collaborator · 2026-10-20
NOT_YET_RECRUITINGTemporal Interference Transcranial Alternating Current Stimulation for Major Depressive DisorderNCT07712159 · collaborator · 2026-10-10
NOT_YET_RECRUITINGChronic Kidney Disease and Metabolic Disorders in the ElderlyNCT07494526 · collaborator · 2026-04-01
NOT_YET_RECRUITINGEfficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.NCT07288749 · collaborator · 2026-01-01
NOT_YET_RECRUITINGNeurobiological Mechanisms of Pathological Rumination and Effects of AripiprazoleNCT06937476 · collaborator · 2025-05-08
ACTIVE_NOT_RECRUITINGEvaluating an Insulin Pump for Time in Range (TIR) in Patients with Type 1 DiabetesNCT06741943 · collaborator · 2024-12-11
NOT_YET_RECRUITINGDrugs studied in this sponsor's trials
15 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing Second Xiangya Hospital of Central South University as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
insulin, regular, human6
placebo5
metformin3
liraglutide2
berberine1
dapagliflozin1
docetaxel1
dulaglutide1
insulin, regular, human RxCUI 253182 · Lead sponsor in 6 linked trial(s) · 0 currently recruiting
6 trials
placebo RxCUI 8375 · Lead sponsor in 3 linked trial(s) · 1 currently recruiting
5 trials
metformin RxCUI 6809 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting
3 trials
liraglutide RxCUI 475968 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting
2 trials
berberine RxCUI 1437 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
dapagliflozin RxCUI 1488564 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
docetaxel RxCUI 72962 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting
1 trial
dulaglutide RxCUI 1551291 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
escitalopram RxCUI 321988 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
fecal microbiota, live RxCUI 2626724 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting
1 trial
inulin RxCUI 5924 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
lorlatinib RxCUI 2103164 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
propranolol hydrochloride RxCUI 82084 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting
1 trial
saxagliptin RxCUI 857974 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
sorafenib RxCUI 495881 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
Sponsor roles
lead sponsor50
collaborator16
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.